Literature DB >> 875318

[Indocyanine green kinetics in newborns with non-hemolytic hyperbilirubinemia (author's transl)].

G Heimann, B Roth, E Gladtke.   

Abstract

The kinetic parameters of indocyanine green elimination from blood were determined after an intravenous load of the dye in a dosage of 2-4 mg per kg body weight in 22 newborns with a non-hemolytic hyperbilirubinemia. Since the uptake of indocyanine green by liver is selectively carried out and the dye is not further metabolised, these kinetic parameters serve as measures for the performance of hepatocellular elimination. 11 of these newborns were treated 5 days previously with 7.5 mg phenobarbital per kg body weight. Compared to the untreated group, the serum bilirubin concentration significantly decreased after treatment with phenobarbital and the parameters of elimination of the dye from blood changed as described by saturation-kinetics. The maximal elimination-rate Vmax and the Michaelis-Menten-constant Km were significantly higher in newborns treated with phenobarbital (71.1 muMol/l-min and 356.4 muMol/l) than in the untreated ones (23.4 muMol/l-min and 100.0 mutmol/l). Kinetic data of indocyanine green elimination gathered in newborns treated with and without phenobarbital support the hypothesis that cytoplasmatic proteins oliver should facilitate the uptake of organic anions inclusively bilirubin into the liver cell. A defiency of such transport proteins may be one of the causes of non-hemolytic hyperbilirubinemia in newborns.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 875318     DOI: 10.1007/bf01488583

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  17 in total

1.  The handling of indocyanine green by the liver.

Authors:  G Paumgartner
Journal:  Schweiz Med Wochenschr       Date:  1975

2.  The plasma removal on indocyanine green and sulfobromophthalein: effect of dosage and blocking agents.

Authors:  D B HUNTON; J L BOLLMAN; H N HOFFMAN
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

3.  Decrease of total serum-bilirubin concentration in newborn infants after phenobarbitone treatment.

Authors:  D Trolle
Journal:  Lancet       Date:  1968-09-28       Impact factor: 79.321

4.  Deficiency of hepatic organic anion-binding protein as a possible cause of non-haemolytic unconjugated hyperbilirubinaemia in the newborn.

Authors:  A J Levi; Z Gatmaitan; I M Arias
Journal:  Lancet       Date:  1969-07-19       Impact factor: 79.321

5.  Hepatic bilirubin UDP-glucuronyl transferase activity and cytochrome P450 content in a surgical population, and the effects of preoperative drug therapy.

Authors:  M Black; R D Perrett; A E Carter
Journal:  J Lab Clin Med       Date:  1973-05

6.  [Bilirubin metabolism in newborn infants].

Authors:  E Gladtke; H Rind
Journal:  Monatsschr Kinderheilkd       Date:  1967-04

7.  Deficiency of hepatic organic anion-binding protein, impaired organic anion uptake by liver and "physiologic" jaundice in newborn monkeys.

Authors:  A J Levi; Z Gatmaitan; I M Arias
Journal:  N Engl J Med       Date:  1970-11-19       Impact factor: 91.245

8.  Phylogenetic study of organic anion transfer from plasma into the liver.

Authors:  R I Levine; H Reyes; A J Levi; Z Gatmaitan; I M Arias
Journal:  Nat New Biol       Date:  1971-06-30

9.  Organic anion-binding protein in rat liver: drug induction and its physiologic consequence.

Authors:  H Reyes; A J Levi; Z Gatmaitan; I M Arias
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

10.  Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions.

Authors:  A J Levi; Z Gatmaitan; I M Arias
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.